Navigation Links
Thermage Announces First Quarter 2008 Financial Results
Date:5/8/2008

on future financial performance, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Thermage, Inc.

NON-GAAP RECONCILIATION OF NET INCOME PER SHARE

(unaudited)

Range of Estimates

From To

2008 GAAP diluted net income per share (a) $0.00 $0.03

Stock-based compensation (b) 0.18 0.18

2008 Non-GAAP diluted net income per share (a) $0.18 $0.21

(a) Reflects weighted average outstanding used in calculating diluted net

income per share of 26 million.

(b) Represents the Company's estimate of stock-based compensation

charges, net of taxes

Thermage, Inc.

CONDENSED STATEMENTS OF OPERATIONS

(in thousands of dollars, except share and per share data)

(unaudited)

Three Months Ended

March 31,

2008 2007

Net revenue $16,231 $15,155

Cost of revenue 4,358 4,152

Gross margin 11,873 11,003

Operating expenses

Sales and marketing 7,422 6,374

Research and development 2,731 2,466

General and ad
'/>"/>

SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Thermage, Inc. to Present at the 10th Annual Needham & Company Growth Conference
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 PuraMed ... developer, and marketer of over-the-counter (OTC) medicinal and ... research opinion on the company based on low ... , Non-Prescription, All Natural Product to Treat ... Product Outperforms #1 Prescription Competitor , Currently ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 PI’s ... wide and provide 15 mm travel range with ... The small dimensions make these new positioners the ... spaces. A vacuum rated version is also available. ... specifications and datasheets can be found at: , ...
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... , May 23, 2013 Z Trim ... value-added ingredients to a variety of industries, announced that ... a panel discussion at this year,s National Restaurant Association ... 2013, on behalf of the Research Chefs Association.  Chef ... Restaurants: The Good, the Bad and the Ugly," joining ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... 25, 2012 Aviir Diagnostic Laboratory announced today ... with MultiPlan, Inc. for ancillary diagnostics laboratory testing. ... PHCS and PHCS Savility Networks. Aviir ... from the Stanford University School of Medicine to ...
... The rise of the corporate venture fund and the ... themes at BioTrinity, the-premier European biopartnering and investment conference ... comprehensive support for bioscience businesses in the Oxford and ... day of the conference saw senior figures from Merck ...
... well-respected, independent, third-party laboratory has tested for Tuberculosis (TB) ... (BioNanoPore) test kits and achieved the detection of ... culture times for conventional technologies take a minimum of ... concurrent tests for TB at the same facility, using ...
Cached Biology Technology:Aviir Laboratories Announce National Agreement With MultiPlan 2Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity 2Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity 3NanoLogix Provides Testing and Operations Update 2NanoLogix Provides Testing and Operations Update 3
(Date:5/23/2013)... Neuron , the team reveal the interplay of brain ... by the Wellcome Trust and BBSRC. , By ... improve our perceptual abilities. While these changes can affect ... affect the fidelity of that response. , ... "When you communicate with others, you can make yourself ...
(Date:5/22/2013)... that can detect molecular variants in chemical mixtures ... most important, though time-consuming, processes in analytical chemistry. ... , post-doctoral researcher David Patterson, Professor of Physics John ... Free-Electron Laser Science (CFEL) in Hamburg, Germany developed a ... molecular variants apart, and to determine how much variant ...
(Date:5/22/2013)... in cellular DNA can endanger the whole organism, as ... at Ludwig-Maximilians-Universitaet (LMU) in Munich now report how byproducts ... helix. , The DNA in our cells controls the ... bodies. The instructions for this are encoded in the ... the bases adenine (A), cytosine (C), guanine (G) and ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3DNA damage: The dark side of respiration 2
... PHILADELPHIA A new study by University of Pennsylvania ... humans, that ventilators combined with diaphragm disuse contributes to ... eighteen hours. Muscle atrophy in the diaphragm is a ... mechanical ventilation often have difficulty breathing after being removed ...
... German . , The "Large Molecule Heimat" ... forming region Sagittarius B2. In this source of only 0,3 ... formed star, most of the interstellar molecules known to date ... ethyl alcohol, formaldehyde, formic acid, acetic acid, glycol aldehyde (a ...
... Humans have regularly been introducing exotic species into ... nutritional necessities or meet less indispensable purposes such ... environments are not always adapted for hosting new ... wild rabbit into Australia or brown fario trout ...
Cached Biology News:Long-term use of mechanical ventilation contributes to the deterioration of human diaphragm muscle 2New organic molecule in space 2Conservation of freshwater fish biodiversity: a challenge for the countries of the South 2Conservation of freshwater fish biodiversity: a challenge for the countries of the South 3
RABBIT ANTI ISOCITRATE DEHYDROGENASE...
dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...
Recombinant Equine IL-4, CF...
VACUGENE PUMP 110V, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: